ESC Late-Breaker: RATE-AF Trial Wearables Study

What is known about the use of wearables and their impact on health outcomes and healthcare use among patients with atrial fibrillation.

In this interview, Dipak Kotecha MBChB, PhD and Sidney C. Smith Jr. MD, MACC, discuss β€œESC Late-Breaker: RATE-AF trial wearables study.”

Related References:

  1. Bunting KV, Stanbury M, Tica O, Kotecha D. Transforming clinical research by involving and empowering patients- the RATE-AF randomized trial. Eur Heart J. 2021 Jul 1;42(25):2411-2414. doi: 10.1093/eurheartj/ehab098. PMID: 33655299; PMCID: PMC8248994.
  2. Bunting KV, Gill SK, Sitch A, Mehta S, O'Connor K, Lip GY, Kirchhof P, Strauss VY, Rahimi K, Camm AJ, Stanbury M, Griffith M, Townend JN, Gkoutos GV, Karwath A, Steeds RP, Kotecha D; RAte control Therapy Evaluation in permanent Atrial Fibrillation (RATE-AF) trial group. Improving the diagnosis of heart failure in patients with atrial fibrillation. Heart. 2021 Jun;107(11):902-908. doi: 10.1136/heartjnl-2020-318557. Epub 2021 Mar 10. PMID: 33692093; PMCID: PMC8142420.

Clinical Topics: Heart Failure and Cardiomyopathies, Acute Heart Failure, Arrhythmias and Clinical EP, Noninvasive Imaging, Prevention, Sports and Exercise Cardiology

Keywords: ACCELLite, Heart Failure


< Back to Listings